Press Release – Neon Mind

Press Release

NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference

Press Release

NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001

Press Release

NeonMind to Participate in Panel Discussion at Lift & Co. Expo’s Psychedelics Business Summit on November 19, 2021

Press Release

NeonMind and SRx Health Solutions Announce Strategic Alliance to Establish Specialty Mental Health Clinics for Interventional Psychiatry Treatments

Press Release

NeonMind Biosciences Named as a Top Industry Innovator in Inaugural Issue of Psychedelia Magazine

Press Release

NeonMind Advances Strategy for Specialty Clinic Launch

Press Release

NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD.

Press Release

NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board

Press Release

NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets

Press Release

NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment Conference

©2021 NeonMind Biosciences Inc.